{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:18:08Z","timestamp":1770887888633,"version":"3.50.1"},"reference-count":40,"publisher":"Oncology Nursing Society (ONS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2007,6,1]]},"DOI":"10.1188\/07.cjon.387-395","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T10:43:20Z","timestamp":1187865800000},"page":"387-395","source":"Crossref","is-referenced-by-count":15,"title":["Totect\u2122: A New Agent for Treating Anthracycline Extravasation"],"prefix":"10.1188","volume":"11","author":[{"given":"Lisa","family":"Schulmeister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,7,10]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Andoh, R., & Ishida, R. (1998). Catalytic inhibitors of DNA topoisomerase II. <i>Biochimica et Biophysica Acta<\/i>, <b>1400<\/b>, 155-171.","DOI":"10.1016\/S0167-4781(98)00133-X"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Barden, G.A. (1980). Venous extravasation of doxorubicin HCl with secondary skin ulceration. <i>Southern Medical Journal<\/i>, <b>73<\/b>, 1543-1544.","DOI":"10.1097\/00007611-198011000-00040"},{"key":"E00003","unstructured":"Bedford Laboratories. (2006). Dexrazoxane [Package insert]. Bedford, OH: Author."},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Bowers, D.G., & Lynch, J.B. (1978). Adriamycin extravasation. <i>Plastic and Reconstructive Surgery<\/i>, <b>61<\/b>, 86-92.","DOI":"10.1097\/00006534-197801000-00015"},{"key":"E00005","unstructured":"Cabriales, S., Bresnahan, J., Testa, D., Espina, B.M., Scadden, D.T., Ross, M., et al. (1998). Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: A report of four cases. <i>Oncology Nursing Forum<\/i>, <b>25<\/b>, 67-70."},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Comas, D., & Mateu, J. (1996). Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion. <i>Annals of Pharmacotherapy<\/i>, <b>30<\/b>, 244-246.","DOI":"10.1177\/106002809603000306"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Di Paolo, A. (2004). Liposomal anticancer therapy: Pharmacokinetic and clinical aspects. <i>Journal of Chemotherapy<\/i>, <b>16<\/b>(Suppl. 4), 90-93.","DOI":"10.1179\/joc.2004.16.Supplement-1.90"},{"key":"E00008","unstructured":"Dorr, R.T., & Alberts, D.S. (1981). Pharmacologic antidotes to experimental doxorubicin skin toxicity: A suggested role for beta-adrenergic compounds. <i>Cancer Treatment Reports<\/i>, <b>65<\/b>, 1001-1006."},{"key":"E00009","unstructured":"El-Saghir, N.S., Mrad, A., Abbas, J., Mufarrij, A., Shamseddine, A., & Salem, Z. (2003). Dexrazoxane is an effective immediate therapy for doxorubicin extravasation [Abstract 580]. <i>Proceedings of the American Society of Clinical Oncology<\/i>, <b>22<\/b>, 145."},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Ener, R.A., Meglathery, S.B., & Styler, M. (2004). Extravasation of systemic hemato-oncological therapies. <i>Annals of Oncology<\/i>, <b>15<\/b>, 858-862.","DOI":"10.1093\/annonc\/mdh214"},{"key":"E00011","doi-asserted-by":"crossref","unstructured":"Frost, A., Gmehling, D., Azemar, M., Unger, C., & Mross, K. (2006). Treatment of anthracycline extravasation with dexrazoxane\u2014 Clinical experience. <i>Onkologie<\/i>, <b>29<\/b>, 314-318.","DOI":"10.1159\/000093480"},{"key":"E00012","unstructured":"Giaccone, G. (2006). <i>Successful treatment of anthracycline extravasation with Savene\u2122 (dexrazoxane). Results from two multicenter prospective clinical studies<\/i>. Presentation at the 31st Congress of the European Society for Medical Oncology, Istanbul, Turkey. Retrieved December 7, 2006, from http:\/\/www.savene.com\/multimedia\/Giaccone_presentation_V2a.pdf"},{"key":"E00013","doi-asserted-by":"crossref","unstructured":"Goolsby, T.V., & Lombardo, F.A. (2006). Extravasation of chemotherapeutic agents: Prevention and treatment. <i>Seminars in Oncology<\/i>, <b>33<\/b>, 139-143.","DOI":"10.1053\/j.seminoncol.2005.11.007"},{"key":"E00014","unstructured":"Hellmann, K. (1998). Overview and historical development of dexrazoxane. <i>Seminars in Oncology<\/i>, <b>25<\/b>(Suppl. 10), 48-54."},{"key":"E00015","unstructured":"Jenkins, J., & Corden, B.J. (1983). Vesicant activity of chemotherapeutic agents. <i>Cancer Treatment Reports<\/i>, <b>67<\/b>, 409."},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Jensen, J.N., Lock-Andersen, J., Langer, S.W., & Mejer, J. (2003). Dexrazoxane\u2014A promising antidote in the treatment of accidental extravasation of anthracyclines. <i>Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery<\/i>, <b>37<\/b>, 174-175.","DOI":"10.1080\/02844310310007791"},{"key":"E00017","unstructured":"Langer, S.W., Sehested, M., & Jensen, P.B. (1999). ICRF-187 (dexrazoxane) inhibits doxorubicin-induced S.C. necrosis in mice: A new strategy in treating accidental anthracycline extravasation [Abstract 695]. <i>Proceedings of the 35th Annual Meeting of the American Society of Clinical Oncology<\/i>, <b>18<\/b>, 695."},{"key":"E00018","unstructured":"Langer, S.W., Sehested, M., & Jensen, P.B. (2000a). Protection against anthracycline induced extravasation injuries with dexrazoxane: Elucidation of the possible mechanism. <i>Proceedings of the American Association for Cancer Research<\/i>, <b>41<\/b>, 492."},{"key":"E00019","unstructured":"Langer, S.W., Sehested, M., & Jensen, P.B. (2000b). Treatment of anthracycline extravasation with dexrazoxane. <i>Clinical Cancer Research<\/i>, <b>6<\/b>, 3680-3686."},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Langer, S.W., Sehested, M., & Jensen, P.B. (2001). Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice. <i>Annals of Oncology<\/i>, <b>12<\/b>, 405-410.","DOI":"10.1023\/A:1011163823321"},{"key":"E00021","unstructured":"Langer, S.W., Sehested, M., Jensen, P.B., Buter, J., & Giaccone, G. (2000). Dexrazoxane in anthracycline extravasation. <i>Journal of Clinical Oncology<\/i>, <b>18<\/b>, 3064."},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Langer, S.W., Thougaard, A.V., Sehested, M., & Jensen, P.B. (2006). Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. <i>Cancer Chemotherapy and Pharmacology<\/i>, <b>57<\/b>, 125-128.","DOI":"10.1007\/s00280-005-0022-7"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Laughlin, R.A., Landeen, J.M., & Habal, M.B. (1979). The management of inadvertent subcutaneous adriamycin infiltration. <i>American Journal of Surgery<\/i>, <b>137<\/b>, 408-412.","DOI":"10.1016\/0002-9610(79)90077-1"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Lokich, J. (1999). Doxil extravasation injury: A case report. <i>Annals of Oncology<\/i>, <b>10<\/b>, 735-736.","DOI":"10.1023\/A:1008364529537"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Luedke, D.W., Kennedy, P.S., & Rietschel, R.L. (1979). Histopathogenesis of skin and subcutaneous injury induced by adriamycin. <i>Plastic and Reconstructive Surgery<\/i>, <b>63<\/b>, 463-465.","DOI":"10.1097\/00006534-197904000-00003"},{"key":"E00026","doi-asserted-by":"crossref","unstructured":"Mehta, P., & Najar, N. (1978). Skin ulceration due to faulty adriamycin administration. <i>Clinical Pediatrics<\/i>, <b>17<\/b>, 663-664.","DOI":"10.1177\/000992287801700813"},{"key":"E00027","unstructured":"Mouridsen, H.T., Langer, S.W., Buter, J., Eidtmann, H., Rosti, G., de Wit, M., et al. (2006a). Successful treatment of anthracycline extravasation with Savene (dexrazoxane). Results from two prospective clinical multicenter studies [Abstract LBA9]. <i>Annals of Oncology<\/i>, <b>17<\/b>(Suppl. 9). Retrieved December 5, 2006, from http:\/\/annonc.oxfordjournals.org\/cgi\/reprint\/17\/suppl_9\/NP-a"},{"key":"E00028","doi-asserted-by":"crossref","unstructured":"Mouridsen, H.T., Langer, S.W., Buter, J., Eidtmann, H., Rosti, G., de Wit, M., et al. (2006b). Treatment of anthracycline extravasation with Savene (dexrazoxane). Results from two prospective clinical multicenter studies. <i>Annals of Oncology<\/i>, <b>18<\/b>, 546-550.","DOI":"10.1093\/annonc\/mdl413"},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Mross, K., van der Vijgh, W.J., Gall, H., Boven, E., & Pinedo, H.M. (1988). Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. <i>Journal of Clinical Oncology<\/i>, <b>6<\/b>, 517-526.","DOI":"10.1200\/JCO.1988.6.3.517"},{"key":"E00030","unstructured":"Pfizer, Inc. (2000). Zinecard\u00ae (dexrazoxane) [Package insert]. New York: Author."},{"key":"E00031","unstructured":"Polovich, M., White, J.M., & Kelleher, L.O. (2005). <i>Chemotherapy and biotherapy guidelines and recommendations for practice<\/i> (2nd ed.). Pittsburgh, PA: Oncology Nursing Society."},{"key":"E00032","doi-asserted-by":"crossref","unstructured":"Reilly, J.J., Neifeld, J.P., & Rosenberg, S.A. (1977). Clinical course and management of accidental adriamycin extravasation. <i>Cancer<\/i>, <b>40<\/b>, 2053-2056.","DOI":"10.1002\/1097-0142(197711)40:5<2053::AID-CNCR2820400509>3.0.CO;2-A"},{"key":"E00033","doi-asserted-by":"crossref","unstructured":"Rudolph, R., Stein, R., & Pattillo, R. (1976). Skin ulcers due to adriamycin. <i>Cancer<\/i>, <b>38<\/b>, 1087-1094.","DOI":"10.1002\/1097-0142(197609)38:3<1087::AID-CNCR2820380308>3.0.CO;2-X"},{"key":"E00034","doi-asserted-by":"crossref","unstructured":"Sauerland, C., Engelking, C., Wickham, R., & Corbi, D. (2006). Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. <i>Oncology Nursing Forum<\/i>, <b>33<\/b>, 1134-1141.","DOI":"10.1188\/06.ONF.1134-1141"},{"key":"E00035","doi-asserted-by":"crossref","unstructured":"Schrijvers, D.L. (2003). Extravasation: A dreaded complication of chemotherapy. <i>Annals of Oncology<\/i>, <b>24<\/b>(Suppl. 3), 26-30.","DOI":"10.1093\/annonc\/mdg744"},{"key":"E00036","unstructured":"Schulmeister, L. (2005). Managing extravasations. <i>Clinical Journal of Oncology Nursing<\/i>, <b>9<\/b>, 472-475."},{"key":"E00037","unstructured":"Schulmeister, L., & Camp-Sorrell, D. (2000). Chemotherapy extravasation from implanted ports. <i>Oncology Nursing Forum<\/i>, <b>27<\/b>, 531-538."},{"key":"E00038","unstructured":"TopoTarget USA, Inc. (2007). Totect\u2122 (dexrazoxane for injection) [Package insert]. Rockaway, NJ: Author."},{"key":"E00039","unstructured":"Westlaw. (2006). Iris Molina and Melvin Molina v. Veronica Zaharia, MD, and \"Jane Doe\" [No. 2002 WL 32117311]. Stamford, CT: Author."},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"Wickham, R., Engelking, C., Sauerland, C., & Corbi, D. (2006). Vesicant extravasation part II: Evidence-based management and continuing controversies. <i>Oncology Nursing Forum<\/i>, <b>33<\/b>, 1143-1150.","DOI":"10.1188\/06\/ONF.1143-1150"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/2Q107PK52373686N.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:10Z","timestamp":1763754670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/11\/3\/totecttm-new-agent-treating-anthracycline-extravasation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6,1]]}},"alternative-id":["2Q107PK52373686N"],"URL":"https:\/\/doi.org\/10.1188\/07.cjon.387-395","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}